Cavalcanti F - Search Results

1

Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.

Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J. Fernández de Arriba A, et al. Among authors: cavalcanti f. Mol Pharmacol. 1999 Apr;55(4):753-60. Mol Pharmacol. 1999. PMID: 10101034

2

Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines.

Almansa C, de Arriba AF, Cavalcanti FL, Gómez LA, Miralles A, Merlos M, García-Rafanell J, Forn J. Almansa C, et al. Among authors: cavalcanti fl. J Med Chem. 2001 Feb 1;44(3):350-61. doi: 10.1021/jm0009383. J Med Chem. 2001. PMID: 11462976

3

Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles.

Almansa C, Alfón J, de Arriba AF, Cavalcanti FL, Escamilla I, Gómez LA, Miralles A, Soliva R, Bartrolí J, Carceller E, Merlos M, García-Rafanell J. Almansa C, et al. Among authors: cavalcanti fl. J Med Chem. 2003 Jul 31;46(16):3463-75. doi: 10.1021/jm030765s. J Med Chem. 2003. PMID: 12877584

4

New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.

Almansa C, Bartrolí J, Belloc J, Cavalcanti FL, Ferrando R, Gómez LA, Ramis I, Carceller E, Merlos M, García-Rafanell J. Almansa C, et al. J Med Chem. 2004 Oct 21;47(22):5579-82. doi: 10.1021/jm040844j. J Med Chem. 2004. PMID: 15481993

5

Synthesis and structure-activity relationship of a new series of potent AT1 selective angiotensin II receptor antagonists: 5-(biphenyl-4-ylmethyl)pyrazoles.

Almansa C, Gómez LA, Cavalcanti FL, de Arriba AF, García-Rafanell J, Forn J. Almansa C, et al. Among authors: cavalcanti fl. J Med Chem. 1997 Feb 14;40(4):547-58. doi: 10.1021/jm9604383. J Med Chem. 1997. PMID: 9046346

6

In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280.

De Arriba AF, Gómez-Casajús LA, Cavalcanti F, Almansa C, García-Rafanell J, Forn J. De Arriba AF, et al. Among authors: cavalcanti f. Eur J Pharmacol. 1996 Dec 30;318(2-3):341-7. doi: 10.1016/s0014-2999(96)00794-7. Eur J Pharmacol. 1996. PMID: 9016924

7

Diphenylpropionic acids as new AT1 selective angiotensin II antagonists.

Almansa C, Gómez LA, Cavalcanti FL, de Arriba AF, Rodríguez R, Carceller E, García-Rafanell J, Forn J. Almansa C, et al. Among authors: cavalcanti fl. J Med Chem. 1996 May 24;39(11):2197-206. doi: 10.1021/jm9508853. J Med Chem. 1996. PMID: 8667363

8

Cardiovascular effects of the novel potassium channel opener UR-8225.

Tamargo J, Pérez O, Delpón E, García-Rafanell J, Gómez L, Cavalcanti F. Tamargo J, et al. Among authors: cavalcanti f. J Cardiovasc Pharmacol. 1995 Aug;26(2):295-305. doi: 10.1097/00005344-199508000-00016. J Cardiovasc Pharmacol. 1995. PMID: 7475055

9

2,2-Dialkylnaphthalen-1-ones as new potassium channel activators.

Almansa C, Gómez LA, Cavalcanti FL, Rodríguez R, Carceller E, Bartrolí J, García-Rafanell J, Forn J. Almansa C, et al. Among authors: cavalcanti fl. J Med Chem. 1993 Jul 23;36(15):2121-33. doi: 10.1021/jm00067a011. J Med Chem. 1993. PMID: 8340916

10

A potent and selective p38 inhibitor protects against bone damage in murine collagen-induced arthritis: a comparison with neutralization of mouse TNFalpha.

Mihara K, Almansa C, Smeets RL, Loomans EE, Dulos J, Vink PM, Rooseboom M, Kreutzer H, Cavalcanti F, Boots AM, Nelissen RL. Mihara K, et al. Among authors: cavalcanti f. Br J Pharmacol. 2008 May;154(1):153-64. doi: 10.1038/bjp.2008.53. Epub 2008 Feb 25. Br J Pharmacol. 2008. PMID: 18297096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page